Shire Pharmaceuticals has just received FDA approval on a new ADD/ADHD drug called Vyvanse. It should be available to consumers by prescription as early as July 2007. Like other ADD medications, Vyvanse is a controlled substance, but it is different from other similar medications in a couple of significant ways:

Since I’ve been writing about medications and Attention Deficit Disorder for the past few posts, I thought I would share this news. I’m not a doctor or a health care professional, and I’m certainly not making a recommendation here – just passing on some information you might not be aware of.

Tell me what you think!

This site uses Akismet to reduce spam. Learn how your comment data is processed.